ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 26 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $138,000 | -35.8% | 36,068 | +1.1% | 0.00% | – |
| Q4 2019 | $215,000 | -20.4% | 35,661 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $270,000 | -37.8% | 35,661 | +11.4% | 0.00% | 0.0% |
| Q2 2019 | $434,000 | +176.4% | 32,011 | +77.5% | 0.00% | – |
| Q1 2018 | $157,000 | -31.7% | 18,035 | -1.9% | 0.00% | – |
| Q4 2017 | $230,000 | +42.9% | 18,388 | -4.7% | 0.00% | – |
| Q3 2017 | $161,000 | -53.1% | 19,300 | -4.5% | 0.00% | -100.0% |
| Q2 2017 | $343,000 | +383.1% | 20,200 | +168.3% | 0.00% | – |
| Q1 2016 | $71,000 | +10.9% | 7,528 | +17.6% | 0.00% | – |
| Q4 2015 | $64,000 | -28.9% | 6,400 | +1.6% | 0.00% | – |
| Q3 2015 | $90,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |